Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease”

607 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 607 results

Not applicableUnknownNCT04511884
What this trial is testing

Screening Microorganism of Cryptogenic Mechanical Pneumonia Through Next Generation Sequencing to Lung Tissue Fluid

Who this might be right for
Cryptogenic Organizing PneumoniaIdiopathic Interstitial Pneumonias
Shanghai Pulmonary Hospital, Shanghai, China 100
Not applicableStudy completedNCT02929017
What this trial is testing

Integrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their Caregivers

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Pittsburgh 140
Large-scale testing (Phase 3)Study completedNCT04708782
What this trial is testing

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics 598
Testing effectiveness (Phase 2)Study completedNCT05185089
What this trial is testing

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
CoughIdiopathic Pulmonary Fibrosis
Nerre Therapeutics Ltd. 80
Not applicableStudy completedNCT04016168
What this trial is testing

Idiopathic Pulmonary Fibrosis and Serum Bank

Who this might be right for
Idiopathic Pulmonary FibrosisLung Diseases, Interstitial
Rennes University Hospital 903
Not applicableStudy completedNCT04864990
What this trial is testing

Dyspnea and Idiopathic Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University Hospital, Lille 51
Testing effectiveness (Phase 2)Looking for participantsNCT06714123
What this trial is testing

Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease

Who this might be right for
Pulmonary Fibrosis, Interstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Vejle Hospital 140
Testing effectiveness (Phase 2)Study completedNCT02136992
What this trial is testing

Clinical Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Pulmonary Hospital, Shanghai, China 160
Not applicableActive Not RecruitingNCT03041623
What this trial is testing

Japanese Idiopathic Interstitial Pneumonias Registry

Who this might be right for
Idiopathic Interstitial Pneumonia
North East Japan Study Group 867
Not applicableUnknownNCT05367349
What this trial is testing

Optimising Screening for Early Disease Detection in Familial Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis Idiopathic Familial
St. Antonius Hospital 200
Large-scale testing (Phase 3)Study completedNCT01979952
What this trial is testing

Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Boehringer Ingelheim 113
Testing effectiveness (Phase 2)Study completedNCT06081621
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 23
Testing effectiveness (Phase 2)Study completedNCT02951429
What this trial is testing

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Who this might be right for
Idiopathic Pulmonary Fibrosis
Hoffmann-La Roche 177
Early research (Phase 1)Study completedNCT03727802
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Toray Industries, Inc 34
Early research (Phase 1)Study completedNCT02871401
What this trial is testing

A Pilot Trial of Herpesvirus Treatment in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Vanderbilt University Medical Center 31
Not applicableStudy completedNCT00512967
What this trial is testing

The Occurence of Inflammation and Oxidative Stress in Lung Diseases

Who this might be right for
Interstitial Lung DiseasesSarcoidosisIdiopathic Pulmonary Fibrosis+1 more
Maastricht University Medical Center 76
Not applicableStudy completedNCT02268981
What this trial is testing

Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Schön Klinik Berchtesgadener Land 18
Testing effectiveness (Phase 2)Study completedNCT00162760
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Johns Hopkins University 19
Post-approval studies (Phase 4)Ended earlyNCT01321996
What this trial is testing

68Ga-DOTA-NOC PET/CT in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 29
Early research (Phase 1)Study completedNCT05817240
What this trial is testing

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Endeavor Biomedicines, Inc. 21
Next Page